从老的细胞中取出新的细胞.

Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021

Same author

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Neuropathology and applied neurobiology·2016

Same author

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2013

Same author

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

Neurology·2011

Same author

The relationship between relapse, impairment and disability in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2011

Same author

Adult stem cells and multiple sclerosis.

Cell proliferation·2011

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

从老的细胞中取出新的细胞.

相关概念视频

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

The relationship between relapse, impairment and disability in multiple sclerosis.

Adult stem cells and multiple sclerosis.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

从老的细胞中取出新的细胞.

相关概念视频

相关文章

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Axonal motor protein KIF5A and associated cargo deficits in multiple sclerosis lesional and normal-appearing white matter.

Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis.

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

The relationship between relapse, impairment and disability in multiple sclerosis.

Adult stem cells and multiple sclerosis.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.